The store will not work correctly when cookies are disabled.
(RR/SS)-2-[1-(3,4-dichlorophenyl)-3-methylbutyl]-1-methylpiperidine
ID: ALA387117
PubChem CID: 16102770
Max Phase: Preclinical
Molecular Formula: C17H25Cl2N
Molecular Weight: 314.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)CC(c1ccc(Cl)c(Cl)c1)C1CCCCN1C
Standard InChI: InChI=1S/C17H25Cl2N/c1-12(2)10-14(17-6-4-5-9-20(17)3)13-7-8-15(18)16(19)11-13/h7-8,11-12,14,17H,4-6,9-10H2,1-3H3
Standard InChI Key: FRKGVKAPAMAQSO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
10.2890 -1.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0074 -0.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7231 -1.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4411 -0.7798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4427 0.0492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7205 0.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0054 0.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5765 -0.7732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5802 0.0527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8717 0.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1545 0.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1503 -0.7650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2863 -2.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1534 -1.1942 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.1568 0.4606 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.8617 -1.1825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8572 -2.0066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9987 -2.4257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9959 -3.2498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7137 -2.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
5 6 1 0
8 16 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 16 1 0
1 2 1 0
1 13 1 0
6 7 2 0
4 14 1 0
7 2 1 0
5 15 1 0
3 4 1 0
1 8 1 0
16 17 1 0
8 9 1 0
13 18 1 0
18 19 1 0
4 5 2 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.30 | Molecular Weight (Monoisotopic): 313.1364 | AlogP: 5.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 1 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.98 | CX LogP: 5.86 | CX LogD: 4.28 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.70 | Np Likeness Score: -0.05 |
References
1. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |
2. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |